Respiratory Care

Inspira Technologies Receives Buy Rating with $2 Price Target, Signaling Major Medical Technology Breakthrough

Inspira Technologies Receives Buy Rating with $2 Price Target, Signaling Major Medical Technology Breakthrough

Litchfield Hills Research initiated coverage of Inspira Technologies with a Buy rating and $2 price target, highlighting the company's innovative respiratory support technology that could revolutionize critical care treatment by offering an alternative to traditional mechanical ventilation.

June 2, 2025
Health Care Originals Wins Top Honors at SuperCrowdLA Pitch Competition with AI Respiratory Monitoring Technology

Health Care Originals Wins Top Honors at SuperCrowdLA Pitch Competition with AI Respiratory Monitoring Technology

Health Care Originals, led by CEO Sharon Samjitsingh, swept the SuperCrowdLA Live Pitch Competition by winning both Judges' and Audience Choice Awards for its innovative AI-powered respiratory monitoring technology, signaling potential breakthrough in chronic respiratory condition management.

May 11, 2025